首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Cyclophosphamide/dexamethasone/doxorubicin liposomal/pegfilgrastimAcute renal failure and bradycardia : 2 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2016年
/ 1604卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-016-18112-y
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:56 / 56
相关论文
共 50 条
[21]
A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma
P S Becker
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
P S Becker
T A Gooley
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
T A Gooley
D J Green
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
D J Green
N Burwick
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
N Burwick
T Y Kim
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
T Y Kim
K Kojouri
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
K Kojouri
Y Inoue
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
Y Inoue
D J Moore
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
D J Moore
E Nelli
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
E Nelli
T Dennie
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
T Dennie
W I Bensinger
论文数:
0
引用数:
0
h-index:
0
机构:
University of Washington,Divisions of Hematology and Medical Oncology
W I Bensinger
Blood Cancer Journal,
2016,
6
: e422
-
e422
[22]
Cyclophosphamide/dexamethasone/thalidomideDeath: 4 case reports
Reactions Weekly,
2016,
1618
(1)
: 65
-
65
[23]
Cyclophosphamide/doxorubicin/epirubicinCardiotoxicity: 5 case reports
Reactions Weekly,
2021,
1863
(1)
: 109
-
109
[24]
Cyclophosphamide/doxorubicin liposomal/paclitaxelOesophageal stenosis and ulceration: case report
Reactions Weekly,
2022,
1904
(1)
: 171
-
171
[25]
Cyclophosphamide/dexamethasone/pomalidomideMild liver impairment and sepsis: 2 case reports
Reactions Weekly,
2024,
2022
(1)
: 99
-
99
[26]
Doxorubicin liposomalCancers, renal failure and other toxicities: 7 case reports
Reactions Weekly,
2011,
1340
(1)
: 19
-
19
[27]
Doxorubicin/pazopanib/sunitinibHeart failure: 2 case reports
Reactions Weekly,
2019,
1766
(1)
: 124
-
124
[28]
Dexamethasone/doxorubicin liposomal/lenalidomideDeep vein thrombosis: case report
Reactions Weekly,
2015,
1533
(1)
: 172
-
172
[29]
Antineoplastics/dexamethasoneSomatotropin deficiency (first report with asparaginase, cyclophosphamide, cytarabine, dexamethasone, doxorubicin, mercaptopurine and tioguanine) in children: 2 case reports
Reactions Weekly,
2006,
1111
(1)
: 6
-
6
[30]
Cyclophosphamide/doxorubicin/paclitaxelCognitive impairment: 4 case reports
Reactions Weekly,
2016,
1586
(1)
: 110
-
110
←
1
2
3
4
5
→